登录

眼科产品制造和批发商LENSRXLAB获得83万美元融资,用于开发两个B2B医疗保健服务平台和糖尿病患者用先进镜片技术

LENSRXLAB Secures $830,000 to Develop Two B2B Healthcare Delivery Platforms and Advanced Lens Technology for Diabetics

businesswire | 2024-04-25 | 翻译由动脉网AI生成,点击反馈

可切换为仅中文


PHILADELPHIA & JACKSONVILLE, Fla.--(BUSINESS WIRE)--Ophthalmic Goods Manufacturing startups Bon Vivant Safety Eyewear Company, Inc. and Tioga Optical Lab QOZB, LLC, founded by Anthony B. Miles, US Navy Trident Nuclear Submarine Force Veteran and Dr. Chelise Firmin, Optometrist, has secured $830,000 in seed funding for the joint venture LENSRXLAB to develop two B2B Healthcare Delivery Platforms and a proprietary Advanced Lens Technology for Diabetics..

佛罗里达州费城和杰克逊维尔市——(商业新闻短讯)——眼科用品制造初创公司Bon Vivant Safety Eyewear Company,Inc.和Tioga Optical Lab QOZB,LLC,由美国海军三叉戟核潜艇部队老兵安东尼·迈尔斯(Anthony B.Miles)和验光师切丽斯·菲尔曼(CheliseFirmin)博士创建,已为合资企业LENSRXLAB获得83万美元的种子资金,用于开发两个B2B医疗服务平台和糖尿病患者专有的先进镜片技术。

Now the duo collectively seeks to raise $3.1 million. The funds will be used to go to market with their two B2B Healthcare Delivery Platforms at scale, production of inventory, hiring key staff and equity toward the build-out and automated production equipment for its 18,629-sf ground-up manufacturing facility to be built adjacent to Temple University Health Sciences Campus in Philadelphia, Pennsylvania to service all 48 U.S.

现在,两人共同寻求筹集310万美元。这些资金将用于规模化的两个B2B医疗保健交付平台的上市、库存生产、雇佣关键员工和股权,用于其18629平方英尺的地面制造设施的扩建和自动化生产设备,该设施将与宾夕法尼亚州费城坦普尔大学健康科学校区相邻,为所有48个美国公司提供服务。

States–Alaska, Hawaii, and U.S. territories (Puerto Rico, Guam, Northern Mariana Islands, U.S. Virgin Islands and American Samoa)..

各州——阿拉斯加、夏威夷和美国领土(波多黎各、关岛、北马里亚纳群岛、美属维尔京群岛和美属萨摩亚)。

Their B2B offerings include LENSRXLAB’s groundbreaking online Supplemental Vision Benefits Platform for Diabetics. Tailored for Hospitals and Medical Clinics, Health Insurance Companies, Corporate Employers, Military/Veteran Organizations, Diabetic Care Centers, Health Programs, and Others, LENSRXLAB offers a new approach with its comprehensive all-in-one single vision, bifocal and progressive diabetic eyewear packages, ensuring accessibility for patients, service members, veterans, beneficiaries, and employees..

他们的B2B产品包括LENSRXLAB开创性的糖尿病患者在线补充视力福利平台。LENSRXLAB为医院和诊所、健康保险公司、企业雇主、军队/退伍军人组织、糖尿病护理中心、健康计划等量身定制,它提供了一种新的方法,具有全面的一体式单视野、双焦点和渐进式糖尿病眼镜套装,确保患者、服务人员、退伍军人、受益人和员工的可访问性。

One new innovation by the duo is DiaVista, a proprietary advanced lens technology powered by Nirtech® with 7 lights with UV + IR protection to be offered through both LENSRXLAB B2B platforms and globally through strategic partners.

这对搭档的一项新创新是DiaVista,这是一种由Nirtech®提供动力的专有先进镜头技术,具有7个紫外线+红外防护灯,将通过LENSRXLAB B2B平台和全球战略合作伙伴提供。

'Our all-in-one diabetic packages represent a holistic approach to vision care, addressing not just visual needs but also prioritizing the medical aspects of diabetic eye health. By integrating advanced technologies and medical-grade materials, we aim to provide comprehensive solutions that promote eye wellness and enhance quality of life for individuals, men, women, and children managing diabetes,' said Dr.

“我们的一体式糖尿病套餐代表了视力护理的整体方法,不仅解决了视力需求,还优先考虑了糖尿病眼睛健康的医学方面。通过整合先进技术和医疗级材料,我们的目标是为管理糖尿病的个人、男性、女性和儿童提供全面的解决方案,促进眼睛健康,提高生活质量。

Chelise Firmin, Optometrist, Founder of LENSRXLAB..

CheliseFirmin,验光师,LENSRXLAB创始人。

LENSRXLAB is also planning to expand its offerings with new products, services, and programs, including The DiaVista Gift Voucher Pilot Program for Diabetic Vision Equity. This program’s annual goal, with the support of corporate sponsors and donors, is to provide fully subsidized, specialized prescription diabetic eyewear packages with its proprietary DiaVista Advanced Lens Technology to over 20,000 low-income individuals, seniors, and veterans..

LENSRXLAB还计划通过新产品、服务和计划扩大其产品范围,包括DiaVista糖尿病视力权益礼品券试点计划。该项目的年度目标是,在企业赞助商和捐赠者的支持下,为20000多名低收入个人、老年人和退伍军人提供完全补贴的专业处方糖尿病眼镜包,以及专有的DiaVista Advanced Lens技术。

Additionally, we plan to introduce an advanced Computer Lens featuring blue light blocking technology to prevent eye strain from everyday digital devices. With 99% light transmission and 99% blocking of HEV radiation, along with 91% blocking of infrared radiation, this lens aims to enhance visual comfort and protect eye health in our increasingly digital world..

此外,我们计划推出一种先进的电脑镜头,采用蓝光阻挡技术,以防止日常数字设备造成眼睛疲劳。该镜头具有99%的透光率和99%的HEV辐射阻挡率,以及91%的红外辐射阻挡率,旨在提高视觉舒适度,保护我们日益数字化的世界中的眼睛健康。

Furthermore, we are launching an animated cartoon series called LENS LEGENDS, weaving together elements of adventure, humor, and education to entertain audiences of all ages while addressing various social determinants of health.

此外,我们正在推出一部名为《镜头传奇》的动画片系列,将冒险、幽默和教育元素交织在一起,以娱乐所有年龄段的观众,同时解决各种健康的社会决定因素。

With the infusion of $3.1 million in funding, LENSRXLAB is poised for remarkable growth and innovation in the diabetic vision care sector. By leveraging this funding to enhance its offerings, expand its reach, and build out its future ophthalmic goods manufacturing facility, LENSRXLAB is primed to revolutionize diabetic eyewear, empowering individuals to manage diabetes with cutting-edge technology and comprehensive vision care..

随着310万美元资金的注入,LENSRXLAB有望在糖尿病视力护理领域实现显着的增长和创新。通过利用这笔资金来增强其产品,扩大其覆盖面,并建设其未来的眼科用品制造设施,LENSRXLAB已准备好彻底改变糖尿病眼镜,使个人能够通过尖端技术和全面的视力护理来管理糖尿病。

To learn more about LENSRXLAB, please visit the www.diavistalenstech.com

要了解LENSRXLAB的更多信息,请访问www.diavistalenstech.com

About LENSRXLAB

透镜xlab

LENSRXLAB is a distinguished Black American and SBA Service-Disabled Veteran-Owned Ophthalmic Goods Manufacturer and Wholesaler Small Business Enterprise. Specializing in prescription safety, diabetic, and dress eyewear, our brands include two B2B Healthcare Delivery Platforms: the LENSRXLAB Supplemental Vision and Health Benefits Platform for Government and Corporate Worksites, and the LENSRXLAB Supplemental Vision Benefits Platform for Diabetics.

LENSRXLAB是一家杰出的美国黑人和SBA服务残疾老兵拥有的眼科用品制造商和批发商小型企业。我们的品牌专注于处方安全、糖尿病和服饰眼镜,包括两个B2B医疗保健服务平台:政府和企业工作场所的LENSRXLAB补充视力和健康福利平台,以及糖尿病患者的LENSRXLAB补充视力福利平台。

Additionally, we offer our proprietary DiaVista Advanced Lens Technology for Diabetics. Our target customers include Federal, State & Municipal Agencies, Military Establishments, Corporate Worksites, Hospitals & Clinics, Health Insurance Companies, Health Programs, and more. Led by Anthony B. Miles, a US Navy Trident Nuclear Submarine Force Veteran, and Dr.

此外,我们为糖尿病患者提供专有的DiaVista Advanced Lens技术。我们的目标客户包括联邦、州和市级机构、军事机构、公司工地、医院和诊所、健康保险公司、健康计划等。由美国海军三叉戟核潜艇部队老兵安东尼·迈尔斯(AnthonyB.Miles)和。

Chelise Firmin, Optometrist, our leadership is rooted in Philadelphia, Pennsylvania, with operations extending to Jacksonville, Florida..

验光师切丽斯·菲尔敏(CheliseFirmin),我们的领导层扎根于宾夕法尼亚州的费城,业务扩展到佛罗里达州的杰克逊维尔。

推荐阅读

用GE HealthCare的SIGNA MAGNUS突破神经科学的边界

businesswire 2024-05-05 18:00

科兴制药:注射用紫杉醇(白蛋白结合型)通过欧盟GMP认证

36kr 2024-05-05 17:45

重药控股枸橼酸托法替布片获得药品注册证书

中国证券网 2024-05-05 17:34

businesswire

6132篇

最近内容 查看更多

用GE HealthCare的SIGNA MAGNUS突破神经科学的边界

5 小时后

UroGen宣布ATLAS的结果显示,在AUA 2024治疗新发和复发的低级别中危非肌肉侵袭性癌症时,UGN-102反应的持久性很强

12 小时前

KCAS Bio和Crux Biolabs宣布在光谱流式细胞术领域建立全球联盟

1 天前

相关公司查看更多

LENSRXLAB

眼科产品制造、批发商

立即沟通

产业链接查看更多

所属赛道

专科医院与诊所
近30天,融资2起
商业保险